AzTrials
AzTrials

Alveolar Bone LossNCT05198011

Three-Dimensional Printed Customized Titanium Mesh for Mandibular Augmentation

A study testing 3D customized Titanium Mesh (Study) in people with Alveolar Bone Loss, run by Hams Hamed Abdelrahman at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Completely or partially edentulous patients suffer from resorption of the alveolar bone, they always seek rehabilitation which becomes challenging. Alveolar ridge augmentation is widely done now to offer these patients functional and esthetic restoration. Read more about this study

Who is it for?
Ages 40 to 60 years
Conditions the study is for
Alveolar Bone Loss
What is being tested?
3D customized Titanium Mesh (Study)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteEgypt
Study dates
1 Oct 2019to 30 Apr 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients will have a posterior mandibular atrophic ridge
  • Distance between the crest of the ridge and the superior border of the inferior alveolar canal will be from 5 mm to 7 m
  • Adequate inter-arch space

Who cannot join

  • Patients who have any uncontrolled systemic disease contraindicated to oral surgery ( Diabetes, hypertension, and patients under chemotherapy treatment )
  • Patients who have any relevant bone disease.
  • Patients who are smokers

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Alexandria Faculty of Dentistry

    Alexandria

Other trials in Egypt

About this study

Official title: Mandibular Ridge Augmentation Using Three-Dimensional Printed Model for Customization of Titanium Mesh

Completely or partially edentulous patients suffer from resorption of the alveolar bone, they always seek rehabilitation which becomes challenging. Alveolar ridge augmentation is widely done now to offer these patients functional and esthetic restoration. Many techniques have been proposed to obtain good results of ridge augmentation. Titanium Mesh (TiMe) is widely used, also digital and computer-guided surgery now plays an important role to improve the techniques and results in ridge augmentation procedures.

Being tested
3D customized Titanium Mesh (Study), Conventional ridge augmentation (Control)
Medical subject headings
Alveolar Bone Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 3D customized Titanium Mesh (Study)Procedure or surgery

    approach for planning and augmenting atrophic posterior mandibular ridge using a pre-customized TiMe on a 3D model. The 3D surgical model will be virtually created from a cone-beam computed tomography (CBCT) and printed using Fused deposition modeling (FDM) machine. The 3D model will be then used to contour the TiMe in accordance with the needed amount of augmentation then will be used to help pack and contour the graft material.

  • Conventional ridge augmentation (Control)Procedure or surgery

    the conventional technique of ridge augmentation using Titanium Mesh

Study groups in NCT05198011
Study groupRoleWhat they receive
3D mandibular ridge augmentationExperimentalNot described
Receives: Procedure: 3D customized Titanium Mesh (Study)
Conventional mandibular ridge augmentationActive comparatorNot described
Receives: Procedure: Conventional ridge augmentation (Control)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in bone volume

    Bone volume wa measured using CBCT

    Measured: at baseline and 6 months

  2. Operation time

    Time of operation for each group will be calculated

    Measured: During the procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jan 2022
  2. Study start1 Oct 2019
  3. Primary completion30 Apr 2020
  4. Study completion30 Apr 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05198011
Sponsor's protocol ID
Augmentation_Maxillo
Status last verified
Jan 2022
First submitted
4 Jan 2022
Last updated
20 Jan 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing 3D customized Titanium Mesh (Study) in people with Alveolar Bone Loss, run by Hams Hamed Abdelrahman at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in bone volume (time frame: at baseline and 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in